ABEO Abeona Therapeutics Inc.

NASDAQ
$5.57

Abeona Therapeutics Inc. (ABEO) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with ABEO's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
7 transactions
Purchases
$0
0 shares
Sales
$981.0K
144,985 shares
Net activity
-$981.0K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $981.0K 7 transactions · 144,985 shares

Largest single sale: $473.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Alvino Mark Director Sell 15,000 $5.86 $88.0K 62,065 −19.5% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 1,478 $6.53 $9.7K 492,079 −0.3% of holding
Seshadri Vishwas Chief Executive Officer Sell 67,971 $6.96 $473.3K 1,306,108 −4.9% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 24,880 $6.96 $173.3K 493,557 −4.8% of holding
Vasanthavada Madhav Chief Commercial Officer Sell 12,606 $6.96 $87.8K 290,623 −4.2% of holding
O'Malley Brendan M. SVP, Chief Legal Officer Sell 12,050 $6.96 $83.9K 427,953 −2.7% of holding
Alland Leila Director Sell 11,000 $5.92 $65.1K 162,614 −6.3% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.